3rd Quarter - Report

TARPLIN STRATEGIES LLC for AMERICAN MEDICAL ASSOCIATION

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid physician payments, health insurance market reforms, delivery system reforms, health care financing options, physician antitrust and malpractice issues, health information technology, prevention and wellness issues, comparative effectiveness research. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid physician payments, health insurance market reforms, delivery system reforms, health care financing options, physician antitrust and malpractice issues, health information technology, prevention and wellness issues, comparative effectiveness research. Quality Measure Development Electronic Health Records - Meaningful Use Regulations Prescription Drug Diversion and Abuse Medicaid program - Parity for primary care physician services Public Law 113-146, Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014, implementation of all provisions.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN Assistant Secretary for Legislation/HHS; Principal Deputy Assistant Secretary for Legislation/HHS; Staff Director, Senate Subcommittee on Children and Families

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE

Medicare/Medicaid MMM

Medicare Program - Long term reform proposals for the Medicare physician payment system. Medicare Program - Regulatory and administrative issues with the Medicare physician formula. Medicare Program - Shared Savings/Accountable Care Organizations Medicare program - Value-based modifier Medicare program - Quality Reporting Programs Medicare program - New payment models/measuring quality performance Medicaid program - Parity for primary care physician services Discussions concerning potential debt limit extension and deficit reduction legislation - physician payment issues. Discussions with congressional staff on misvalued coding issues. Medicaid program - Parity for primary care physician services H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - Medicare physician payment reform. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - Medicare physician payment reform and CHIP extension.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN Assistant Secretary for Legislation/HHS; Principal Deputy Assistant Secretary for Legislation/HHS; Staff Director, Senate Subcommittee on Children and Families

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1470 (114th), S. 810 (114th)

Pharmacy PHA

Public Law 112-144, the Food and Drug Administration Safety and Innovation Act - implementation issues related to reauthorization of user fees for prescription drug, medical device, and biologics approval - Regulation of online pharmacies and prescription painkillers. Prescriber Education and CME Training FDA and HHS recommendations for rescheduling certain drugs.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN Assistant Secretary for Legislation/HHS; Principal Deputy Assistant Secretary for Legislation/HHS; Staff Director, Senate Subcommittee on Children and Families

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.